Literature DB >> 25410553

Use of prescribed opioids by children and adolescents: Differences between Denmark, Norway and Sweden.

M Mahic1, O M Fredheim2,3,4, P C Borchgrevink2,3, S Skurtveit1,5.   

Abstract

BACKGROUND: There are few studies on the use of opioids among children and adolescents. The aim of this study was to determine the 1-year prevalence of prescribed opioid dispensing in Denmark, Norway and Sweden, and to compare gender and age differences in the use of weak and strong opioids between the three countries.
METHODS: Data on the dispensing of opioids were collected from the websites of the complete national prescription databases in the three countries. All individuals aged 0-19 with at least one prescription of opioids during the study period were included.
RESULTS: The 1-year prevalence of opioid use among young individuals aged 0-19 years increased during the study period (2006-2012) in Denmark from 2.5 to 3.4 per thousand, in Norway from 10.7 to 13.4 per thousand and in Sweden from 5.9 to 7.1 per thousand. In all three countries, more boys than girls used opioids between the ages of 0 and 10, whereas girls were the major users in the age range 11-19. Use of opioids in all three countries was dominated by weak opioids, codeine being the most dominant in Norway and Sweden and tramadol in Denmark.
CONCLUSIONS: The 1-year prevalence of prescribed opioid use among children and adolescents in Norway was far higher than in Denmark and Sweden. During the study period, an increasing use of opioids among children and adolescents was observed in all three countries.
© 2014 European Pain Federation - EFIC®

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410553     DOI: 10.1002/ejp.632

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  5 in total

1.  Development of the Adolescent Opioid Safety and Learning (AOSL) scale using exploratory factor analysis.

Authors:  Olufunmilola Abraham; Tanvee Thakur; Kelsey Brasel; Derek Norton; Claire A Rosenberger
Journal:  Res Social Adm Pharm       Date:  2021-06-12

2.  High Rates of Tramadol Use among Treatment-Seeking Adolescents in Malmö, Sweden: A Study of Hair Analysis of Nonmedical Prescription Opioid Use.

Authors:  Martin O Olsson; Agneta Öjehagen; Louise Brådvik; Robert Kronstrand; Anders Håkansson
Journal:  J Addict       Date:  2017-12-24

Review 3.  When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.

Authors:  Frédérique Rodieux; Laszlo Vutskits; Klara M Posfay-Barbe; Walid Habre; Valérie Piguet; Jules A Desmeules; Caroline F Samer
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

4.  The Protective and Restorative Effects of Growth Hormone and Insulin-Like Growth Factor-1 on Methadone-Induced Toxicity In Vitro.

Authors:  Erik Nylander; Sofia Zelleroth; Fred Nyberg; Alfhild Grönbladh; Mathias Hallberg
Journal:  Int J Mol Sci       Date:  2018-11-17       Impact factor: 5.923

5.  Opioid Analgesic Prescription in French Children: A National Population-Based Study.

Authors:  Samira Choufi; Simon Mounier; Etienne Merlin; Emmanuelle Rochette; Jessica Delorme; Nicolas Authier; Chouki Chenaf
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.